← Back to Fringe
Federal Judge Overturns Trump Administration Ban on HIV Grants for Gender-Affirming Care
Fringe By Michael A.G. · Nov 22, 2026

Federal Judge Overturns Trump Administration Ban on HIV Grants for Gender-Affirming Care

A federal judge in Boston has ruled that the Trump administration's restrictions on using Ryan White HIV/AIDS Program grants for gender-affirming care are unconstitutional. U.S. District Judge William G. Young issued his decision on November 19, finding that the restrictions violated the First Amendment's free speech protections and the Fifth Amendment's guarantee of equal protection under the law.

The Ryan White HIV/AIDS Program was established by Congress in 1990 to provide care for low-income and uninsured individuals living with HIV. In March of this year, the Department of Health and Human Services (HHS) imposed new grant conditions that barred recipients from using program funds for "gender-affirming" medical interventions or activities promoting what the government deemed as "gender ideology." The restrictions were part of a broader directive issued by President Donald Trump in January 2025 through an executive order aimed at protecting women's rights and freedom of conscience.

Judge Young's ruling specifically addressed how these restrictions prevented grant recipients from providing gender-affirming care even when they were operating outside the federally funded program. The judge criticized the administration's actions, stating that they represented a departure from the United States' tradition of generosity, compassion, and diversity. He further noted that the restrictions were based on animus, loathing, and discrimination.

Dr. José M. Zuniga, president emeritus of the International Association of Providers of AIDS Care—one of the plaintiffs in the case—praised the ruling for lifting a significant burden from clinics reliant on federal grants. Dr. Zuniga highlighted that these restrictions put healthcare providers in conflict with their ethical obligations to patients, particularly those seeking comprehensive care that includes discussions about gender identity and hormone therapy.

The Department of Justice had argued that the program's statute does not explicitly include "gender-affirming care" among its list of core medical services, thus allowing HHS to interpret allowable uses of funds within the context of statutory guidelines. However, Judge Young disagreed with this interpretation, emphasizing that such restrictions disproportionately impact individuals who rely on federal funding for critical healthcare services.

The Trump administration defended its actions by asserting that these measures were necessary to keep grant conditions aligned with Congress's original intent in establishing the Ryan White HIV/AIDS Program. The Justice Department maintained that HHS has historically issued guidelines regarding allowable uses of funds within this program, and it was within their authority to do so now.

Despite the ruling, the White House did not immediately respond to requests for comment on the decision. This case underscores the ongoing debate over federal regulations impacting healthcare providers and their ability to offer comprehensive care that respects patients' gender identities and related medical needs. The implications of this legal victory extend beyond HIV/AIDS treatment, potentially influencing broader discussions about LGBTQ+ rights and access to healthcare services in the United States.

← Back to Fringe